Showing results (11-20 of 325) with videos related to
Sort By:
Pageof 33
Expert Opinion on Medical Diagnostics|March 19, 2013
Novel molecular prognostic markers in breast cancerTrishna Goswami, Minal Shah, Claudine IsaacsCancer|September 26, 2023
Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: Implications for breast cancer-related adverse health eventsJean M Mitchell, Thomas DeLeire, Claudine IsaacsClinical Advances in Hematology & Oncology : H&O|April 12, 2021
Neratinib: an option for HER2-positive metastatic breast cancerJoyce A O'Shaughnessy, Ruth O'Regan, Claudine IsaacsClinical Advances in Hematology & Oncology : H&O|April 12, 2021
Neratinib in the early-stage/extended adjuvant breast cancer patientJoyce A O'Shaughnessy, Claudine Isaacs, Ruth O'ReganBreast Cancer Research and Treatment|April 4, 2018
Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patientsMarc D Schwartz, Beth N Peshkin, Claudine Isaacs, et al.Breast Disease|July 23, 2011
BRCA1/2 mutations and triple negative breast cancersBeth N Peshkin, Michelle L Alabek, Claudine IsaacsJournal of Telemedicine and Telecare|November 15, 2021
Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomesSavannah Binion, Lia J Sorgen, Beth N Peshkin, et al.Breast Cancer Research and Treatment|January 3, 2020
Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patientsMara Tynan, Beth N Peshkin, Claudine Isaacs, et al.Breast Disease|October 6, 2007
Susceptibility to breast cancer: hereditary syndromes and low penetrance genesRachel Nusbaum, Kristen J Vogel, Kaylene ReadyClinical and Translational Medicine|October 6, 2017
Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinibNarayan Shivapurkar, Eveline E Vietsch, Erin Carney, et al.Pageof 33